<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33713321</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of molecular neuroscience : MN</Title><ISOAbbreviation>J Mol Neurosci</ISOAbbreviation></Journal><ArticleTitle>Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases.</ArticleTitle><Pagination><StartPage>1410</StartPage><EndPage>1424</EndPage><MedlinePgn>1410-1424</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12031-021-01818-6</ELocationID><Abstract><AbstractText>Accumulation of misfolded tau, amyloid &#x3b2; (A&#x3b2;), and alpha-synuclein (&#x3b1;-syn) proteins is the fundamental contributor to many neurodegenerative diseases, namely Parkinson's (PD) and AD. Such protein aggregations trigger activation of immune mechanisms in neuronal and glial, mainly M1-type microglia cells, leading to release of pro-inflammatory mediators, and subsequent neuronal dysfunction and apoptosis. Despite the described neurotoxic features for glial cells, recruitment of peripheral leukocytes to the brain and their conversion to neuroprotective M2-type microglia can mitigate neurodegeneration by clearing extracellular protein accumulations or residues. Based on these observations, it was speculated that Dendritic cell (DC)-based vaccination, by making use of DCs as natural adjuvants, could be used for treatment of neurodegenerative disorders. DCs potentiated by disease-specific antigens can also enhance T helper 2 (Th2)-specific immune response and by production of specific antibodies contribute to clearance of intracellular aggregations, as well as enhancing regulatory T cell response. Thus, enhancement of immune response by DC vaccine therapy can potentially augment glial polarization into the neuroprotective phenotype, enhance antibody production, and at the same time balance neuronal cells' repair, renewal, and protection. The characteristic feature of this method of treatment is to maintain the equilibrium in the immune response rather than targeting a single mediator in the disease and their application in other neurodegenerative diseases should be addressed. However, the safety of these methods should be investigated by clinical trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabahi</LastName><ForeName>Mohammadmahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshaghanian</LastName><ForeName>Asef</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolatshahi</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabbari</LastName><ForeName>Parnian</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Genomics and Bioinformatics, University of California, Riverside, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmani</LastName><ForeName>Farzaneh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaei</LastName><ForeName>Nima</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3836-1827</Identifier><AffiliationInfo><Affiliation>Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Children's Medical Center Hospital, Dr. Qarib St, Keshavarz Blvd, 14194, Tehran, Iran. rezaei_nima@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Neurosci</MedlineTA><NlmUniqueID>9002991</NlmUniqueID><ISSNLinking>0895-8696</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019581" MajorTopicYN="N">Neuropil</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adjuvant therapy</Keyword><Keyword MajorTopicYN="N">Dendritic cell-based vaccination</Keyword><Keyword MajorTopicYN="N">Dendritic cells</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33713321</ArticleId><ArticleId IdType="doi">10.1007/s12031-021-01818-6</ArticleId><ArticleId IdType="pii">10.1007/s12031-021-01818-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmadi S, Sabahi M, Haddadi R (2018) The preventive/protective effect of testosterone on haloperidol-induced extrapyramidal disorders in male rats. J Babol Univ Med Sci 20:55&#x2013;62</Citation></Reference><Reference><Citation>Ahmadian N, Hejazi S, Mahmoudi J, Talebi M (2018) Tau pathology of Alzheimer disease: possible role of sleep deprivation. Basic Clin Neurosci 9:307</Citation><ArticleIdList><ArticleId IdType="pubmed">30719245</ArticleId><ArticleId IdType="pmc">6360494</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G, Vukosavic S, Romero N, Przedborski S (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72:2415&#x2013;2425</Citation><ArticleIdList><ArticleId IdType="pubmed">10349851</ArticleId></ArticleIdList></Reference><Reference><Citation>Anandasabapathy N et al (2011) Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J Exp Med 208:1695&#x2013;1705</Citation><ArticleIdList><ArticleId IdType="pubmed">21788405</ArticleId><ArticleId IdType="pmc">3149213</ArticleId></ArticleIdList></Reference><Reference><Citation>Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN (2014) Clinical use of dendritic cells for cancer therapy. Lancet Oncol 15:e257&#x2013;e267</Citation><ArticleIdList><ArticleId IdType="pubmed">24872109</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel SH, Zhao W, Beers D, Henkel J (2011) The microglial-motoneuron dialogue in ALS. Acta Myologica 30:4</Citation><ArticleIdList><ArticleId IdType="pubmed">21842586</ArticleId><ArticleId IdType="pmc">3185827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae EJ et al (2012) Antibody-aided clearance of extracellular &#x3b1;-synuclein prevents cell-to-cell aggregate transmission. J Neurosci 32:13454&#x2013;13469. https://doi.org/10.1523/jneurosci.1292-12.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.1292-12.2012</ArticleId><ArticleId IdType="pubmed">23015436</ArticleId><ArticleId IdType="pmc">3752153</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch K et al (2015) Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer&#x2019;s disease pathology. Nat Commun 6:1&#x2013;12</Citation></Reference><Reference><Citation>Beers DR et al (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103:16021&#x2013;16026. https://doi.org/10.1073/pnas.0607423103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId><ArticleId IdType="pmc">1613228</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR et al (2011) Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134:1293&#x2013;1314</Citation><ArticleIdList><ArticleId IdType="pubmed">21596768</ArticleId><ArticleId IdType="pmc">3097891</ArticleId></ArticleIdList></Reference><Reference><Citation>Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J (2004) Reduced &#x3b2;-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 279:46907&#x2013;46914</Citation><ArticleIdList><ArticleId IdType="pubmed">15345711</ArticleId></ArticleIdList></Reference><Reference><Citation>Block ML, Zecca L, Hong J-S (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57</Citation><ArticleIdList><ArticleId IdType="pubmed">17180163</ArticleId><ArticleId IdType="pmc">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Boss&#xf9; P, Spalletta G, Caltagirone C, Ciaramella A (2015) Myeloid dendritic cells are potential players in human neurodegenerative diseases. Front Immunol 6:632</Citation><ArticleIdList><ArticleId IdType="pubmed">26734003</ArticleId><ArticleId IdType="pmc">4679857</ArticleId></ArticleIdList></Reference><Reference><Citation>Brezovakova V, Valachova B, Hanes J, Novak M, Jadhav S (2018) Dendritic cells as an alternate approach for treatment of neurodegenerative disorders. Cell Mol Neurobiol 1&#x2013;8</Citation></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis New England. J Med 377:162&#x2013;172</Citation></Reference><Reference><Citation>Butovsky O, Kunis G, Koronyo-Hamaoui M, Schwartz M (2007) Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer&#x2019;s disease model European. J Neurosci 26:413&#x2013;416</Citation></Reference><Reference><Citation>Cagnin A et al (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461&#x2013;467</Citation><ArticleIdList><ArticleId IdType="pubmed">11513911</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C, Lin X, Zhang C, Wahi MM, Wefes I, Arendash G, Potter H (2008) Mutant amyloid-beta-sensitized dendritic cells as Alzheimer&#x2019;s disease vaccine. J Neuroimmunol 200:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="pubmed">18649951</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao S, Fisher DW, Rodriguez G, Yu T, Dong H (2021) Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice. J Neuroinflammation 18:10. https://doi.org/10.1186/s12974-020-02054-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02054-2</ArticleId><ArticleId IdType="pubmed">33407625</ArticleId><ArticleId IdType="pmc">7789762</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo X et al (2019) Re-thinking the etiological framework of neurodegeneration. Front Neurosci 13:728. https://doi.org/10.3389/fnins.2019.00728</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00728</ArticleId><ArticleId IdType="pubmed">31396030</ArticleId><ArticleId IdType="pmc">6667555</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS (2009) Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+ CD25+ regulatory T cell function. Clin Immunol 131:260&#x2013;270</Citation><ArticleIdList><ArticleId IdType="pubmed">19171501</ArticleId><ArticleId IdType="pmc">2701651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Sikl&#xf3;s L, Appel SH (1998) Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol 55:1075&#x2013;1080</Citation><ArticleIdList><ArticleId IdType="pubmed">9708957</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung ES et al (2015) Bee venom phospholipase A2, a novel Foxp3+ regulatory T cell inducer, protects dopaminergic neurons by modulating neuroinflammatory responses in a mouse model of Parkinson&#x2019;s disease. J Immunol 195:4853&#x2013;4860</Citation><ArticleIdList><ArticleId IdType="pubmed">26453752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaramella A et al (2010) Increased pro-inflammatory response by dendritic cells from patients with Alzheimer&#x2019;s disease. J Alzheimers Dis 19:559&#x2013;572</Citation><ArticleIdList><ArticleId IdType="pubmed">20110602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaramella A et al (2013a) The stimulation of dendritic cells by amyloid beta 1&#x2013;42 reduces BDNF production in Alzheimer&#x2019;s disease patients. Brain Behav Immun 32:29&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pubmed">23578995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaramella A et al (2013b) Blood dendritic cell frequency declines in idiopathic Parkinson&#x2019;s disease and is associated with motor symptom severity. PLoS One 8:e65352</Citation><ArticleIdList><ArticleId IdType="pubmed">23776473</ArticleId><ArticleId IdType="pmc">3679103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaramella A et al (2009) Amyloid &#x3b2; peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells. Neurobiol Aging 30:210&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">17658667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccocioppo F et al (2019a) The characterization of regulatory T-cell profiles in Alzheimer&#x2019;s disease and multiple sclerosis. Sci Rep 9:1&#x2013;9</Citation></Reference><Reference><Citation>Ciccocioppo F et al (2019b) The characterization of regulatory T-Cell profiles in Alzheimer&#x2019;s disease and multiple sclerosis. Sci Rep 9:8788. https://doi.org/10.1038/s41598-019-45433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45433-3</ArticleId><ArticleId IdType="pubmed">31217537</ArticleId><ArticleId IdType="pmc">6584558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluskey S, Ramsden D (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol 54:386</Citation><ArticleIdList><ArticleId IdType="pubmed">11724913</ArticleId><ArticleId IdType="pmc">1187128</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton CA (2013) Immune heterogeneity in neuroinflammation: dendritic cells in the brain. J Neuroimmune Pharmacol 8:145&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pubmed">23114889</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 25:675&#x2013;683</Citation><ArticleIdList><ArticleId IdType="pubmed">15172747</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai BS, Monahan AJ, Carvey PM, Hendey B (2007) Blood-brain barrier pathology in Alzheimer&#x2019;s and Parkinson&#x2019;s disease: implications for drug therapy. Cell Transplant 16:285&#x2013;299. https://doi.org/10.3727/000000007783464731</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/000000007783464731</ArticleId><ArticleId IdType="pubmed">17503739</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER et al (2018) Global, regional, and national burden of Parkinson&#x2019;s disease, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939&#x2013;953. https://doi.org/10.1016/S1474-4422(18)30295-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30295-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Double KL et al (2009) Anti-melanin antibodies are increased in sera in Parkinson&#x2019;s disease. Exp Neurol 217:297&#x2013;301. https://doi.org/10.1016/j.expneurol.2009.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.03.002</ArticleId><ArticleId IdType="pubmed">19289120</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelenboom P, Hack C, Rozemuller J, Stam F (1988) Complement activation in amyloid plaques in Alzheimer&#x2019;s dementia. Virchows Archiv B 56:259</Citation></Reference><Reference><Citation>El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432&#x2013;438. https://doi.org/10.1038/nm1555</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1555</ArticleId><ArticleId IdType="pubmed">17351623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fani Maleki A, Rivest S (2019) Innate immune cells: monocytes, monocyte-derived macrophages and microglia as therapeutic targets for Alzheimer&#x2019;s disease and multiple sclerosis. Front Cell Neurosci 13:355. https://doi.org/10.3389/fncel.2019.00355</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00355</ArticleId><ArticleId IdType="pubmed">31427930</ArticleId><ArticleId IdType="pmc">6690269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher Y, Nemirovsky A, Baron R, Monsonego A (2011) Dendritic cells regulate amyloid-&#x3b2;-specific T-cell entry into the brain: the role of perivascular amyloid-&#x3b2;. J Alzheimers Dis 27:99&#x2013;111</Citation><ArticleIdList><ArticleId IdType="pubmed">21765208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S et al (2020) Early-onset familial alzheimer disease variant PSEN2 N141I heterozygosity is associated with altered microglia phenotype. J Alzheimers Dis 77:675&#x2013;688. https://doi.org/10.3233/JAD-200492</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200492</ArticleId><ArticleId IdType="pubmed">32741831</ArticleId><ArticleId IdType="pmc">7592656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh BB, Cheatem DM, Sheng JR, Vasu C, Prabhakar BS (2009) GM-CSF-induced CD11c+ CD8a&#x2014;dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 21:269&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">19174473</ArticleId><ArticleId IdType="pmc">2645781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L et al (2015) Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice. J Exp Med 212:469&#x2013;480. https://doi.org/10.1084/jem.20132423</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132423</ArticleId><ArticleId IdType="pubmed">25779632</ArticleId><ArticleId IdType="pmc">4387281</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vallejo J et al (2014) CNS myelin induces regulatory functions of DC-SIGN&#x2013;expressing, antigen-presenting cells via cognate interaction with MOG. J Exp Med 211:1465&#x2013;1483</Citation><ArticleIdList><ArticleId IdType="pubmed">24935259</ArticleId><ArticleId IdType="pmc">4076586</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D et al (2020) Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer&#x2019;s disease. Nature 577:399&#x2013;404. https://doi.org/10.1038/s41586-019-1895-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1895-7</ArticleId><ArticleId IdType="pubmed">31915375</ArticleId><ArticleId IdType="pmc">7445078</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D&#x2019;Ambrosi N (2017) The dual role of microglia in ALS: mechanisms and therapeutic approaches. Front Aging Neurosci 9:242. https://doi.org/10.3389/fnagi.2017.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId><ArticleId IdType="pmc">5524666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendelman HE, Appel SH (2011) Neuroprotective activities of regulatory T cells. Trends Mol Med 17:687</Citation><ArticleIdList><ArticleId IdType="pubmed">21996344</ArticleId><ArticleId IdType="pmc">5892451</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech 10:499&#x2013;502. https://doi.org/10.1242/dmm.030205</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.030205</ArticleId><ArticleId IdType="pubmed">28468935</ArticleId><ArticleId IdType="pmc">5451177</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201</Citation><ArticleIdList><ArticleId IdType="pubmed">25441979</ArticleId><ArticleId IdType="pmc">4258012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopisetty A, Bhattacharya P, Haddad C, Bruno JC, Vasu C, Miele L, Prabhakar BS (2013) OX40L/Jagged1 cosignaling by GM-CSF&#x2013;induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells. J Immunol 190:5516&#x2013;5525</Citation><ArticleIdList><ArticleId IdType="pubmed">23630352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gringhuis SI, Kaptein TM, Wevers BA, Mesman AW, Geijtenbeek TB (2014) Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKK&#x3b5;-and CYLD-dependent Bcl3 activation. Nat Commun 5:3898</Citation><ArticleIdList><ArticleId IdType="pubmed">24867235</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Manjili MH, Subjeck JR, Sarkar D, Fisher PB, Wang X-Y (2013) Therapeutic cancer vaccines: past, present, and future. In: Advances in cancer research, vol 119. Elsevier, p 421&#x2013;475</Citation></Reference><Reference><Citation>Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10. https://doi.org/10.3389/fphar.2019.01008</Citation></Reference><Reference><Citation>Halassa MM, Haydon PG (2010) Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72:335&#x2013;355</Citation><ArticleIdList><ArticleId IdType="pubmed">20148679</ArticleId><ArticleId IdType="pmc">3117429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer&#x2019;s disease. J Cell Biol 217:459&#x2013;472. https://doi.org/10.1083/jcb.201709069</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709069</ArticleId><ArticleId IdType="pubmed">29196460</ArticleId><ArticleId IdType="pmc">5800817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart DN (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245&#x2013;3287</Citation><ArticleIdList><ArticleId IdType="pubmed">9345009</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K et al (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10:5816. https://doi.org/10.1038/s41467-019-13812-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13812-z</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId><ArticleId IdType="pmc">6925219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemonnot A-L, Hua J, Ulmann L, Hirbec H (2019) Microglia in alzheimer disease: well-known targets and new opportunities. Front Aging Neurosci 11. https://doi.org/10.3389/fnagi.2019.00233</Citation></Reference><Reference><Citation>Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T, Van Leuven F (2005) Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP [V717I] transgenic mice. J Neuroinflammation 2:22</Citation><ArticleIdList><ArticleId IdType="pubmed">16212664</ArticleId><ArticleId IdType="pmc">1274341</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS et al (2013) Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med 5:64&#x2013;79. https://doi.org/10.1002/emmm.201201544</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS et al (2004a) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221&#x2013;235. https://doi.org/10.1002/ana.10805</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS et al (2004b) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Nuerol 55:221&#x2013;235</Citation></Reference><Reference><Citation>Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term potentiation depends on release of D-serine from astrocytes. Nature 463:232</Citation><ArticleIdList><ArticleId IdType="pubmed">20075918</ArticleId><ArticleId IdType="pmc">2807667</ArticleId></ArticleIdList></Reference><Reference><Citation>Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358</Citation><ArticleIdList><ArticleId IdType="pubmed">25991443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A (1996) Neuropathology of ALS: an overview. Neurology 47:63S-66S</Citation></Reference><Reference><Citation>Hwang C-S, Liu G-T, Chang MD-T, Liao I-L, Chang H-T (2013) Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis. Neurobiol Dis 58:13&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">23639787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C-S, Tsai C-H, Liu G-T, Li W, Chang H-T (2016) Decreased level of serum autoantibody against LG72 is a biosignature of amyotrophic lateral sclerosis. Biomark Med 10:73&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">26673967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain P, Coisne C, Enzmann G, Rottapel R, Engelhardt B (2010) &#x3b1;4&#x3b2;1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis. J Immunol 184:7196&#x2013;7206</Citation><ArticleIdList><ArticleId IdType="pubmed">20483748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YS et al (2007) A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21:179&#x2013;187</Citation></Reference><Reference><Citation>Kleindienst P, Brocker T (2003) Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170:2817&#x2013;2823</Citation><ArticleIdList><ArticleId IdType="pubmed">12626531</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsilieri E, Lutz M, Scheller C (2013a) Autoimmunity, dendritic cells and relevance for Parkinson&#x2019;s disease. J Neural Transm 120:75&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pubmed">22699458</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsilieri E, Lutz MB, Scheller C (2013b) Autoimmunity, dendritic cells and relevance for Parkinson&#x2019;s disease. J Neural Transm (Vienna) 120:75&#x2013;81. https://doi.org/10.1007/s00702-012-0842-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-012-0842-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hyeon SJ, Im H, Ryu H, Kim Y, Ryu H (2016) Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol 25:233&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">27790057</ArticleId><ArticleId IdType="pmc">5081469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemere CA, Masliah E (2010) Can Alzheimer disease be prevented by amyloid-&#x3b2; immunotherapy? Nat Rev Neurol 6:108</Citation><ArticleIdList><ArticleId IdType="pubmed">20140000</ArticleId><ArticleId IdType="pmc">2864089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X et al (2019) Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol 137:825&#x2013;836. https://doi.org/10.1007/s00401-019-01974-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01974-5</ArticleId><ArticleId IdType="pubmed">30805666</ArticleId><ArticleId IdType="pmc">6482120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindestam Arlehamn CS et al (2020) &#x3b1;-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson&#x2019;s disease. Nat Commun 11:1875. https://doi.org/10.1038/s41467-020-15626-w</Citation></Reference><Reference><Citation>Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS (2002) Role of nitric oxide in inflammation&#x2010;mediated neurodegeneration. Ann NY Acad Sci 962:318-331</Citation></Reference><Reference><Citation>Liu SCW, Dickson DW, Brosnan CF (1993) Cytokine Production by Human Fetal Microglia and Astrocytes</Citation></Reference><Reference><Citation>Ludewig P et al (2016) Dendritic cells in brain diseases. Biochim Biophys Acta (BBA)-Mol Basis Dis 1862:352&#x2013;367</Citation></Reference><Reference><Citation>Luo Z et al (2012) Efficacy of a therapeutic vaccine using mutated &#x3b2;-amyloid sensitized dendritic cells in Alzheimer&#x2019;s mice. J Neuroimmune Pharmacol 7:640&#x2013;655</Citation><ArticleIdList><ArticleId IdType="pubmed">22684353</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A, Puentes F, Amor S (2014) Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol 27:117&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Manocha GD et al (2016) APP Regulates microglial phenotype in a mouse model of alzheimer&#x2019;s disease. J Neurosci 36:8471&#x2013;8486. https://doi.org/10.1523/jneurosci.4654-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.4654-15.2016</ArticleId><ArticleId IdType="pubmed">27511018</ArticleId><ArticleId IdType="pmc">4978805</ArticleId></ArticleIdList></Reference><Reference><Citation>Marciani DJ (2015) Alzheimer&#x2019;s disease vaccine development: a new strategy focusing on immune modulation. J Neuroimmunol 287:54&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pubmed">26439962</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowicz S, Engleman EG (1990) Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Investig 85:955&#x2013;961</Citation><ArticleIdList><ArticleId IdType="pubmed">2179270</ArticleId><ArticleId IdType="pmc">296516</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563&#x2013;604</Citation><ArticleIdList><ArticleId IdType="pubmed">23516985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mildner A et al (2011) Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer&#x2019;s disease. J Neurosci 31:11159&#x2013;11171. https://doi.org/10.1523/jneurosci.6209-10.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.6209-10.2011</ArticleId><ArticleId IdType="pubmed">21813677</ArticleId><ArticleId IdType="pmc">6623351</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsonego A, Imitola J, Zota V, Oida T, Weiner HL (2003) Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells. J Immunol 171:2216&#x2013;2224. https://doi.org/10.4049/jimmunol.171.5.2216</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.5.2216</ArticleId><ArticleId IdType="pubmed">12928365</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsonego A, Maron R, Zota V, Selkoe DJ, Weiner HL (2001) Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer&#x2019;s disease. Proc Natl Acad Sci USA 98:10273&#x2013;10278. https://doi.org/10.1073/pnas.191118298</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.191118298</ArticleId><ArticleId IdType="pubmed">11517335</ArticleId><ArticleId IdType="pmc">56951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabar NR et al (2012) Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer&#x2019;s disease in APP+ PS1 mice. PLoS One 7:e49468</Citation><ArticleIdList><ArticleId IdType="pubmed">23226497</ArticleId><ArticleId IdType="pmc">3513317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols E et al (2019) Global, regional, and national burden of Alzheimer&#x2019;s disease and other dementias, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:88&#x2013;106. https://doi.org/10.1016/S1474-4422(18)30403-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30403-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberl&#xe4;nder U et al (2011) Neuromelanin is an immune stimulator for dendritic cells in vitro. BMC Neurosci 12:116</Citation><ArticleIdList><ArticleId IdType="pubmed">22085464</ArticleId><ArticleId IdType="pmc">3225309</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM (2005) A possible role for humoral immunity in the pathogenesis of Parkinson&#x2019;s disease. Brain 128:2665&#x2013;2674</Citation><ArticleIdList><ArticleId IdType="pubmed">16219675</ArticleId></ArticleIdList></Reference><Reference><Citation>Papachroni K et al (2007) Autoantibodies to alpha-synuclein in inherited Parkinson&#x2019;s disease. J Neurochem 101:749&#x2013;756. https://doi.org/10.1111/j.1471-4159.2006.04365.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04365.x</ArticleId><ArticleId IdType="pubmed">17448146</ArticleId><ArticleId IdType="pmc">3154646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pashenkov M, Teleshova N, Link H (2003) Inflammation in the central nervous system: the role for dendritic cells. Brain Pathol 13:23&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">12580542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, Vargas MR (2017) Role and therapeutic potential of astrocytes in amyotrophic lateral sclerosis. Curr Pharm Des 23:5010&#x2013;5021. https://doi.org/10.2174/1381612823666170622095802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId><ArticleId IdType="pmc">5740017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzurro GA, Barrio MM (2015) Dendritic cell-based vaccine efficacy: aiming for hot spots. Front Immunol 6:91</Citation><ArticleIdList><ArticleId IdType="pubmed">25784913</ArticleId><ArticleId IdType="pmc">4347494</ArticleId></ArticleIdList></Reference><Reference><Citation>Polazzi E, Contestabile A (2002) Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 13:221&#x2013;242</Citation><ArticleIdList><ArticleId IdType="pubmed">12405226</ArticleId></ArticleIdList></Reference><Reference><Citation>Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson&#x2019;s disease. Mol Brain 10:53. https://doi.org/10.1186/s13041-017-0340-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0340-9</ArticleId><ArticleId IdType="pubmed">29183391</ArticleId><ArticleId IdType="pmc">5706368</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS (2002) Microglia enhance &#x3b2;-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83:973&#x2013;983</Citation><ArticleIdList><ArticleId IdType="pubmed">12421370</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C, Brinck-Jensen N-S, Zang M, Chen K (2014) Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases. Int J Infect Dis 19:1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">24216295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, Evdokimidis I (2012) Alterations of T cell subsets in ALS: a systemic immune activation? Acta Neurol Scand 125:260&#x2013;264. https://doi.org/10.1111/j.1600-0404.2011.01528.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2011.01528.x</ArticleId><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE (2010) Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson&#x2019;s disease. J Immunol 184:2261&#x2013;2271</Citation><ArticleIdList><ArticleId IdType="pubmed">20118279</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer&#x2019;s disease. Neurobiol Aging 9:339&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pubmed">3263583</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ramos M, von Euler CM, Sanchez-Guajardo V (2014) Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Hum Vaccin Immunother 10:852&#x2013;867</Citation><ArticleIdList><ArticleId IdType="pubmed">24670306</ArticleId><ArticleId IdType="pmc">4896576</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusconi M et al (2017) Inflammatory role of dendritic cells in amyotrophic lateral sclerosis revealed by an analysis of patients&#x2019; peripheral blood. Sci Rep 7:7853</Citation><ArticleIdList><ArticleId IdType="pubmed">28798369</ArticleId><ArticleId IdType="pmc">5552769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabahi M, Ahmadi SA, Haddadi R (2020) The effect of chronic administration of buspirone, 8-ohdpat and different doses of fluoxetine on haloperidol induced extrapyramidal disorders and general locomotor activity in male rats. &#x416;yp&#x43d;a&#x43b; &#x432;&#x44b;c&#x448;e&#x439; &#x43d;ep&#x432;&#x43d;o&#x439; &#x434;e&#x44f;&#x442;e&#x43b;&#x44c;&#x43d;oc&#x442;&#x438; &#x438;&#x43c; &#x418;&#x41f; &#x41f;a&#x432;&#x43b;o&#x432;a 70:473&#x2013;487</Citation></Reference><Reference><Citation>Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG, Jain P (2012) Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood&#x2013;brain barrier through paracellular transmigration and ERK activation. J Neuroinflammation 9:245</Citation><ArticleIdList><ArticleId IdType="pubmed">23102113</ArticleId><ArticleId IdType="pmc">3533869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Guajardo V, Annibali A, Jensen PH, Romero-Ramos M (2013a) &#x3b1;-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. J Neuropathol Exp Neurol 72:624&#x2013;645</Citation><ArticleIdList><ArticleId IdType="pubmed">23771222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M (2013b) Neuroimmunological processes in Parkinson's disease and their relation to &#x3b1;-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro 5:AN20120066</Citation></Reference><Reference><Citation>Saunders JAH et al (2012) CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson&#x2019;s disease. J Neuroimmune Pharmacol 7:927&#x2013;938</Citation><ArticleIdList><ArticleId IdType="pubmed">23054369</ArticleId><ArticleId IdType="pmc">3515774</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura CA et al (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42:23&#x2013;36. https://doi.org/10.1016/s0896-6273(04)00182-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(04)00182-5</ArticleId><ArticleId IdType="pubmed">15066262</ArticleId><ArticleId IdType="pmc">15066262</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt T, Steger M-M, Pavelka M, Grubeck-Loebenstein B (1997) Interactions of the alzheimer &#x3b2; amyloid fragment (25&#x2013;35) with peripheral blood dendritic cells. Mech Ageing Dev 94:223&#x2013;232</Citation><ArticleIdList><ArticleId IdType="pubmed">9147374</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutt CR, Gendelman HE, Mosley RL (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson&#x2019;s disease. Mol Neurodegener 13:1&#x2013;17</Citation></Reference><Reference><Citation>Sheean RK et al (2018) Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol 75:681&#x2013;689</Citation><ArticleIdList><ArticleId IdType="pubmed">29507931</ArticleId><ArticleId IdType="pmc">5885208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng JR, Muthusamy T, Prabhakar BS, Meriggioli MN (2011) GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis. J Neuroimmunol 240:65&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">22099723</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer&#x2019;s disease. Neuron 49:489&#x2013;502. https://doi.org/10.1016/j.neuron.2006.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.01.022</ArticleId><ArticleId IdType="pubmed">16476660</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LM, Schiess MC, Coffey MP, Klaver AC, Loeffler DA (2012) &#x3b1;-Synuclein and anti-&#x3b1;-synuclein antibodies in Parkinson&#x2019;s disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls. PLoS One 7:e52285. https://doi.org/10.1371/journal.pone.0052285</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052285</ArticleId><ArticleId IdType="pubmed">23284971</ArticleId><ArticleId IdType="pmc">3524108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue A et al (2021) Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer&#x2019;s disease. Acta Neuropathol Commun 9:1. https://doi.org/10.1186/s40478-020-01099-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01099-x</ArticleId><ArticleId IdType="pubmed">33402227</ArticleId><ArticleId IdType="pmc">7786928</ArticleId></ArticleIdList></Reference><Reference><Citation>Song GJ, Suk K (2017) Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front Aging Neurosci 9:139&#x2013;139. https://doi.org/10.3389/fnagi.2017.00139</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00139</ArticleId><ArticleId IdType="pubmed">28555105</ArticleId><ArticleId IdType="pmc">5430023</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142&#x2013;1162</Citation><ArticleIdList><ArticleId IdType="pubmed">4573839</ArticleId><ArticleId IdType="pmc">2139237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D et al (2017) T cells from patients with Parkinson&#x2019;s disease recognize &#x3b1;-synuclein peptides. Nature 546:656&#x2013;661. https://doi.org/10.1038/nature22815</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22815</ArticleId><ArticleId IdType="pubmed">28636593</ArticleId><ArticleId IdType="pmc">5626019</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson MEV et al (2020) Identification of a dysfunctional microglial population in human Alzheimer&#x2019;s disease cortex using novel single-cell histology image analysis. Acta Neuropathol Commun 8:170. https://doi.org/10.1186/s40478-020-01047-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01047-9</ArticleId><ArticleId IdType="pubmed">33081847</ArticleId><ArticleId IdType="pmc">7576851</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H (2013) Roles of glial cells in neuroinflammation and neurodegeneration. Clin Exp Neuroimmunol 4:2&#x2013;16. https://doi.org/10.1111/cen3.12059</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarkowski E, Wallin A, Regland B, Blennow K, Tarkowski A (2001) Local and systemic GM-CSF increase in Alzheimer&#x2019;s disease and vascular dementia. Acta Neurol Scand 103:166&#x2013;174. https://doi.org/10.1034/j.1600-0404.2001.103003166.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2001.103003166.x</ArticleId><ArticleId IdType="pubmed">11240564</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197</Citation><ArticleIdList><ArticleId IdType="pubmed">27830784</ArticleId><ArticleId IdType="pmc">5585017</ArticleId></ArticleIdList></Reference><Reference><Citation>Teismann P et al (2003) Pathogenic role of glial cells in Parkinson&#x2019;s disease. Mov Disord 18:121&#x2013;129. https://doi.org/10.1002/mds.10332</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.10332</ArticleId><ArticleId IdType="pubmed">12539204</ArticleId></ArticleIdList></Reference><Reference><Citation>Town T, Tan J, Flavell RA, Mullan M (2005) T-cells in alzheimer&#x2019;s disease. Neuromol Med 7:255&#x2013;264. https://doi.org/10.1385/NMM:7:3:255</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:7:3:255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugen KE et al (2015) Evaluation of an &#x3b1; synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease. Hum Vaccin Immunother 11:922&#x2013;930</Citation><ArticleIdList><ArticleId IdType="pubmed">25714663</ArticleId><ArticleId IdType="pmc">4514430</ArticleId></ArticleIdList></Reference><Reference><Citation>Utagawa A, Bramlett HM, Daniels L, Lotocki G, Dekaban GA, Weaver LC, Dietrich WD (2008) Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Res 1207:155&#x2013;163</Citation><ArticleIdList><ArticleId IdType="pubmed">18374312</ArticleId><ArticleId IdType="pmc">2435262</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P (1999) Cytokines associated with amyloid plaques in Alzheimer&#x2019;s disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol 160:289&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">10630213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F et al (2015) The combined treatment of amyloid-&#x3b2;1-42-stimulated bone marrow&#x2013;derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer&#x2019;s disease in APPswe/PSENldE9 mice. Neurobiol Aging 36:111&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">25085784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O (2018) The multi-dimensional roles of astrocytes in ALS. Neurosci Res 126:31&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanamandra K, Gruden MA, Casaite V, Me&#x161;kys R, Forsgren L, Morozova-Roche L (2011) &#x3b1;-Synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients. PloS One 6:e18513. https://doi.org/10.1371/journal.pone.0018513</Citation></Reference><Reference><Citation>Zappia M et al (2002) Anti-GM1 ganglioside antibodies in Parkinson's disease. Acta Neurol Scand 106:54-57.&#xa0; https://doi.org/10.1034/j.1600-0404.2002.01240.x &#xa0;</Citation></Reference><Reference><Citation>Zhang W et al (2005) Aggregated &#x3b1;-synuclein activates microglia: a process leading to disease progression in Parkinson&#x2019;s disease. FASEB J 19:533&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">15791003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH (2013) Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 8:888&#x2013;899</Citation><ArticleIdList><ArticleId IdType="pubmed">23881705</ArticleId><ArticleId IdType="pmc">4126425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W et al (2017) Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurol 74:677&#x2013;685</Citation><ArticleIdList><ArticleId IdType="pubmed">28437540</ArticleId><ArticleId IdType="pmc">5822209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Liao B, Henkel JS, Appel SH (2012) Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis 48:418&#x2013;428</Citation><ArticleIdList><ArticleId IdType="pubmed">22820142</ArticleId><ArticleId IdType="pmc">3897268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q et al (2020) Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Mol Med 12:e10919. https://doi.org/10.15252/emmm.201910919</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910919</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74&#x2013;e80</Citation><ArticleIdList><ArticleId IdType="pubmed">20628149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer&#x2019;s disease and other disorders. Nat Rev Neurosci 12:723&#x2013;738. https://doi.org/10.1038/nrn3114</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3114</ArticleId><ArticleId IdType="pubmed">22048062</ArticleId><ArticleId IdType="pmc">4036520</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>